BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34872798)

  • 21. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
    Dye C
    J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
    Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants.
    Kiravu A; Osawe S; Happel AU; Nundalall T; Wendoh J; Beer S; Dontsa N; Alinde OB; Mohammed S; Datong P; Cameron DW; Rosenthal K; Abimiku A; Jaspan HB; Gray CM
    Front Immunol; 2019; 10():2307. PubMed ID: 31649662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada.
    Cook VJ; Hernández-Garduño E; Kunimoto D; Hershfield ES; Fanning EA; Hoeppner VH; Elwood RK; FitzGerald JM;
    Can Respir J; 2005 Apr; 12(3):134-8. PubMed ID: 15875064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis.
    Kelly P; McKeown D; Clancy L
    Eur Respir J; 1997 Mar; 10(3):619-23. PubMed ID: 9072995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of universal BCG vaccination of Japanese infants.
    Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T
    Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective audit of neonatal BCG vaccination in Grampian, Scotland.
    Savul S; Duthie S
    Hum Vaccin Immunother; 2023 Dec; 19(3):2281737. PubMed ID: 38175950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.
    Martinez L; Cords O; Liu Q; Acuna-Villaorduna C; Bonnet M; Fox GJ; Carvalho ACC; Chan PC; Croda J; Hill PC; Lopez-Varela E; Donkor S; Fielding K; Graham SM; Espinal MA; Kampmann B; Reingold A; Huerga H; Villalba JA; Grandjean L; Sotgiu G; Egere U; Singh S; Zhu L; Lienhardt C; Denholm JT; Seddon JA; Whalen CC; García-Basteiro AL; Triasih R; Chen C; Singh J; Huang LM; Sharma S; Hannoun D; Del Corral H; Mandalakas AM; Malone LL; Ling DL; Kritski A; Stein CM; Vashishtha R; Boulahbal F; Fang CT; Boom WH; Netto EM; Lemos AC; Hesseling AC; Kay A; Jones-López EC; Horsburgh CR; Lange C; Andrews JR
    Lancet Glob Health; 2022 Sep; 10(9):e1307-e1316. PubMed ID: 35961354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
    Faust L; Schreiber Y; Bocking N
    BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis.
    Ditkowsky JB; Schwartzman K
    PLoS One; 2014; 9(1):e83526. PubMed ID: 24454706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial.
    Stensballe LG; Ravn H; Birk NM; Kjærgaard J; Nissen TN; Pihl GT; Thøstesen LM; Greisen G; Jeppesen DL; Kofoed PE; Pryds O; Sørup S; Aaby P; Benn CS
    J Pediatric Infect Dis Soc; 2019 Jul; 8(3):213-220. PubMed ID: 29635419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guérin (BCG) vaccines from different sources, Kazakhstan.
    Favorov M; Ali M; Tursunbayeva A; Aitmagambetova I; Kilgore P; Ismailov S; Chorba T
    PLoS One; 2012; 7(3):e32567. PubMed ID: 22427854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age-period-cohort analysis.
    Dhamnetiya D; Patel P; Jha RP; Shri N; Singh M; Bhattacharyya K
    BMC Pulm Med; 2021 Nov; 21(1):375. PubMed ID: 34784911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis.
    Hermans S; Boulle A; Caldwell J; Pienaar D; Wood R
    J Int AIDS Soc; 2015; 18(1):20240. PubMed ID: 26411694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of the Evolving Human Immunodeficiency Virus Response on the Epidemiology of Tuberculosis in South African Children and Adolescents.
    du Preez K; Osman M; Seddon JA; Naidoo P; Schaaf HS; Munch Z; Dunbar R; Mvusi L; Dlamini SS; Hesseling AC
    Clin Infect Dis; 2021 Aug; 73(4):e967-e975. PubMed ID: 33532853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
    Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP
    Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacille Calmette-Guérin vaccine-related disease in HIV-infected children: a systematic review.
    Azzopardi P; Bennett CM; Graham SM; Duke T
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1331-44. PubMed ID: 19861003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial.
    Hawkridge A; Hatherill M; Little F; Goetz MA; Barker L; Mahomed H; Sadoff J; Hanekom W; Geiter L; Hussey G;
    BMJ; 2008 Nov; 337():a2052. PubMed ID: 19008268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in Childhood Nontuberculous Mycobacterial Infections After Bacille Calmette-Guérin Coverage Drop: A Nationwide, Population-Based Retrospective Study, Finland, 1995-2016.
    Kontturi A; Soini H; Ollgren J; Salo E
    Clin Infect Dis; 2018 Sep; 67(8):1256-1261. PubMed ID: 29584893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The bacille Calmette-Guérin vaccine may reduce the general child morbidity].
    Nissen TN; Thøstesen LM; Birk NM; Pihl G; Kjærgaard J; Stensballe LG
    Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.